Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2003
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207401 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207399 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207398 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207397 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207396 For pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207395 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207394 Novel proteins and nucleic acids encoding same
11/06/2003US20030207393 Cbp86, a sperm specific protein
11/06/2003US20030207392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207391 Used to prevent dimerisation of vascular endothelial growth factor (VEGF)
11/06/2003US20030207390 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207389 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207388 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207387 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207386 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207385 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207384 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207383 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207382 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207381 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207380 For diagnosis and treatment of estrogenic disorder of mutant ER alpha
11/06/2003US20030207379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207378 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207377 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207376 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207374 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207373 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207372 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207371 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207370 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207369 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207368 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207366 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207365 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207364 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207363 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207362 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207361 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207360 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207359 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207358 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207357 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207356 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207355 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207354 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207353 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/06/2003US20030207352 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207351 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207350 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207349 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2003US20030207348 For predetermination, diagnosis, and therapy for related disorders
11/06/2003US20030207347 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation
11/06/2003US20030207341 Methods for determining compounds capable of inhibiting the activities of the Ha-ras oncogene
11/06/2003US20030207339 PCAM-1 marker protein, nucleic acid sequences encoding PCAM-1 and immunoassays for detection of PCAM-1
11/06/2003US20030207337 Olfactory receptors for isovaleric acid and related malodorants and use thereof in assays for identification of blockers of malodor
11/06/2003US20030207330 Fibrinogen binding moieties
11/06/2003US20030207324 Immunotherapy by modulation of antigen presentation
11/06/2003US20030207318 Kinesin-like motor protein
11/06/2003US20030207316 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
11/06/2003US20030207315 Anti-aging nucleic acid and protein targets
11/06/2003US20030207313 Oligonucleotide for detection and identification of Mycobacteria
11/06/2003US20030207301 Assay for the detection of factors that modulate the expression of INGAP
11/06/2003US20030207299 Involves nucleic acid and amino acid sequences of human kinases; used in the diagnosis, treatment, and prevention of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders
11/06/2003US20030207293 Cryptic-like secreted protein
11/06/2003US20030207291 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
11/06/2003US20030207288 G-protein coupled receptor (GPCR)-like retinoid acid induced molecule differentially expressed in an animal model; Compositions and methods pertaining to treatment and diagnosis of metabolic disorders, such as diabetes, obesity
11/06/2003US20030207287 Non-stochastic generation of genetic vaccines
11/06/2003US20030207286 Nucleic acid sequences showing enhanced expression in benign neuroblastoma compared with acritical human neuroblastoma
11/06/2003US20030207285 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing prognosing disorders related to the polypeptides
11/06/2003US20030207283 Isolated polynucleotide encoding a novel phosphate transporter in plants and a method of modulating phosphate uptake in plants
11/06/2003US20030207282 Method to amplify variable sequences without imposing primer sequences
11/06/2003US20030207276 For diagnosis
11/06/2003US20030207272 Composition and methods for detection of von willebrand's disease
11/06/2003US20030207262 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/06/2003US20030207252 Treatment and diagnostic drugs, kits
11/06/2003US20030207228 Interactive dental restorative network
11/06/2003US20030206927 Methods for isolating and using fungal hemolysins
11/06/2003US20030206926 Characterized by the loss of its capability to reproductively replicate in human cell lines.
11/06/2003US20030206925 Isolated, recombinantly-generated, negative-sense, single-stranded RNA viruses having one or more mutations and/or deletions which reduce repression normally caused by V protein
11/06/2003US20030206922 Siderophore receptor polypeptides (SRPs) and porins from gram negative microbes and no greater than 10.0 endotoxin units per milliliter lipopolysaccharide; or SRPs isolated from a gram positive microbe; treating infectious diseases in cattle
11/06/2003US20030206921 Chlamydia antigens and corresponding DNA fragments and uses thereof
11/06/2003US20030206919 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
11/06/2003US20030206918 Compositions and methods for the therapy and diagnosis of ovarian cancer
11/06/2003US20030206917 Transferring a protein to a cell by coating the cell surface with a lipidated protein; and contacting said cell with a fusion protein having affinity for said lipidated protein and capable of binding to a cell surface receptor
11/06/2003US20030206916 Immunogenic peptides
11/06/2003US20030206915 Extracellular proteins
11/06/2003US20030206910 Poloxamer 188, Poloxamer 237, Poloxamer 338, Poloxamer 124, Poloxamer 401, Tetronic 904, Tetronic 908, Tetronic 1107 or Tetronic 90R4; especially for treating chronic hepatitis and cancer
11/06/2003US20030206908 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
11/06/2003US20030206905 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
11/06/2003US20030206904 Method and therapeutic compositions for the treatment of myocardial infarction
11/06/2003US20030206902 Administering an antagonist of a vascular endothelial cadherin; and administering an antagonist of a vascular endothelial growth factor receptor.
11/06/2003US20030206899 Vascular endothelial cell growth factor antagonists
11/06/2003US20030206892 Methods of modulating activity of DXR
11/06/2003US20030206891 Constructs comprising DNA sequences derived from sequences encoding the proteins FRAP, Tor1, Tor2 and other proteins capable of binding to FKBP:rapamycin
11/06/2003US20030206889 Methods of treating anemia using recombinant adeno-associated virus virions
11/06/2003US20030206888 Herpes simplex virus strains
11/06/2003US20030206887 RNA interference mediated inhibition of hepatitis B virus (HBV) using short interfering nucleic acid (siNA)
1 ... 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 ... 2916